The Global Preimplantation Genetics Diagnosis (PGD) Market is Predict to reach $159.8 Million by 2028, at a CAGR of 9.7%

Published Date: 31-May-2022

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Preimplantation Genetics Diagnosis (PGD) Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Preimplantation Genetics Diagnosis (PGD) Market size is expected to reach $159.8 million by 2028, rising at a Market growth of 9.7% CAGR during the forecast period.

The Chromosomal Abnormalities segment is showcasing a CAGR of 8.9% during (2022 - 2028). This is due to an increase in the number of patients suffering from genetic disorders. In addition, the growth of the segment would further be driven by growing public knowledge of embryo genetic testing. Moreover, the rise in infertility rates and the rise in inherited disorders boosted Market expansion.

Asia Pacific is the fastest growing region in the Global Preimplantation Genetics Diagnosis (PGD) Market by Region in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $44.1 million by 2028. The Europe Market is estimated to witness a CAGR of 9% during (2022 - 2028). Additionally, The North America Market would exhibit a CAGR of 8.5% during (2022 - 2028).

Full Report:

The Market research report has exhaustive quantitative insights providing a clear picture of the Market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the Market have been discussed in the report with the elaborated company profiles of Illumina, Inc., Invitae Corporation, Natera, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics Incorporated, Reproductive Genetic Innovations, PacGenomics, CeGaT GmbH, and Laboratory Corporation of America Holdings.

Global Preimplantation Genetics Diagnosis (PGD) Market Segmentation

By Test Type

  • Aneuploidy
  • Chromosomal Abnormalities
  • X-linked diseases
  • Single Gene Disorders
  • HLA Typing
  • Gender selection
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Illumina, Inc.
  • Invitae Corporation
  • Natera, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Quest Diagnostics Incorporated
  • Reproductive Genetic Innovations
  • PacGenomics
  • CeGaT GmbH
  • Laboratory Corporation of America Holdings

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Preimplantation Genetics Diagnosis (PGD) Market Future Scope & Opportunities 2022-2028

Europe Preimplantation Genetics Diagnosis (PGD) Market Size & Growth Forecast 2022-2028

Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market Size, Share & Industry Outlook to 2028

LAMEA Preimplantation Genetics Diagnosis (PGD) Market Growth, Trends & Forecasts 2022-2028

Request a Free Sample Copy

Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.